Director Dealing

Summary by AI BETAClose X

On September 30, 2025, 4basebio PLC announced that CEO Dr. Heikki Lanckriet purchased 2,000 ordinary shares on September 29, 2025. The aggregated purchase price was 749 pence. Following this transaction, Dr. Lanckriet's total shareholding is 1,119,688 shares, representing 7.21% of the company's issued share capital. The 2,000 shares acquired represent approximately 0.01% of the company's issued share capital, which comprises 15,538,518 ordinary shares. The transactions took place on the London Stock Exchange.

Disclaimer*

Companies

4basebio (4BB)
UK 100

Latest directors dealings